Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.
about
A Broad Overview and Review of CRISPR-Cas Technology and Stem CellsAnimal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?Plant artificial chromosome technology and its potential application in genetic engineeringEngineering RNA-binding proteins with diverse activitiesProgress and Prospects of Anti-HBV Gene Therapy DevelopmentChromatin organization in pluripotent cells: emerging approaches to study and disrupt functionAnemia: progress in molecular mechanisms and therapiesZebrafish as a disease model for studying human hepatocellular carcinomaAtherogenesis and metabolic dysregulation in LDL receptor-knockout rats.CRISPR/Cas9: Transcending the Reality of Genome Editing.Genome Editing and Muscle Stem Cells as a Therapeutic Tool for Muscular Dystrophies.Frameshift indels introduced by genome editing can lead to in-frame exon skipping.Genome engineering in cattle: recent technological advancements.Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.2015 Guidelines for Establishing Genetically Modified Rat Models for Cardiovascular Research.A 90-Day Feeding Study in Rats to Assess the Safety of Genetically Engineered Pork.Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells.Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense.CT-Finder: A Web Service for CRISPR Optimal Target Prediction and Visualization.Detection of nucleotide-specific CRISPR/Cas9 modified alleles using multiplex ligation detection.Application of CRISPR/Cas9 genome editing to the study and treatment of disease.Toward stem cell-based phenotypic screens for neurodegenerative diseases.Fcγ receptors: genetic variation, function, and disease.Society for Pediatric Research 2015 Young Investigator Award: genetics of human hematopoiesis-what patients can teach us about blood cell production.Human Germline Genome Editing.Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.The Gene Targeting Approach of Small Fragment Homologous Replacement (SFHR) Alters the Expression Patterns of DNA Repair and Cell Cycle Control Genes.Transcriptional control of chondrocyte specification and differentiation.Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.Genetics and Genomics of Coronary Artery Disease.Emerging cellular and gene therapies for congenital anemias.Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy.Oligo- and dsDNA-mediated genome editing using a tetA dual selection system in Escherichia coli.Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.Neurology--the next 10 years.Self-cleaving ribozymes enable the production of guide RNAs from unlimited choices of promoters for CRISPR/Cas9 mediated genome editing.Evolution of the SPX gene family in plants and its role in the response mechanism to phosphorus stress.Recent Advances in Nucleic Acid Targeting Probes and Supramolecular Constructs Based on Pyrene-Modified Oligonucleotides.The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.Novel Thrombotic Function of a Human SNP in STXBP5 Revealed by CRISPR/Cas9 Gene Editing in Mice.
P2860
Q26741371-E0777714-5A11-4CA2-A7CD-7FD7FC3302D3Q26777022-292FA8E8-D65A-46F5-B664-2A2FDFE4EE2EQ26787071-F119F9E3-5985-4589-8FAE-CAA31A2725CFQ26795472-118702EB-14CA-4206-8A25-DC39C3ACBEAFQ26799228-EC956F12-A169-4C83-8D02-7FA399FB021AQ26800018-B568DEF3-78C1-41C7-B095-EC48591BE3CBQ27023172-7A52356E-C860-4DC4-AEF0-6506393909B1Q28081542-0BCD8EDE-9B97-444F-B036-40B6AECF29A0Q30968588-4CA3C683-5966-46C3-9C9E-F04CD81E82CEQ33632925-17CF9D0B-005F-4E65-990E-C8B920DB5D63Q33729585-A061C772-862B-4E6D-99CD-8551B68C2B6AQ33751947-B0B4ABE0-53F0-40C7-8115-57A4CCBEE241Q34042998-C61B1133-6B99-4088-83FB-5AEABE2B24F1Q34045952-93C41C35-9D78-4CE0-BB36-3D04AEDFD803Q34474018-05D993EA-3868-4684-8A81-2CD096F1751BQ36182195-79C863C2-8F14-4C7C-B6DA-DA160932E78FQ36450196-37E023D3-2825-485D-859C-BBC3D85918B4Q36730743-23496720-A5AB-46CA-8FBA-906121B57962Q36925529-3A2C5454-AAFD-4478-ADE7-16F8FF37BC46Q37202520-2EF576C2-ED3B-45CE-9EE5-A12CBDEC569EQ38397580-8B7A2F82-9B89-4E15-AD26-4F1BBF74EDBEQ38489289-F87FC401-4C78-487F-8271-E3790F78B88FQ38615347-32E8564E-1EBC-433B-B3F4-D3E134EB3504Q38635450-D57FA266-BAEC-41D2-BBCB-BFEAAAEE90B4Q38646763-4F67DFBB-3209-4A43-B411-404012DB5E49Q38727158-B14B56AD-91E7-4BE0-8408-B223E76FD1C4Q38780656-70D4CAA7-7F6D-478B-998E-ABEA28CBB7FFQ38803469-B8DE372B-8B23-45AF-B5FE-7F778C784E76Q38916142-F935AE30-23A7-454D-98B4-1D450A3496A4Q38944185-9692ED28-A68B-418D-B4D3-682D11B6E670Q38993825-7BCCE226-C171-4065-8C72-FB3FB7C2B6F5Q39026510-06DD6EBA-D606-4AA6-8775-162B62A77F2EQ41047949-90420021-0D8E-44A9-9A19-36427FC7AD11Q45875285-699BE7BE-E2E9-494A-A653-186CA83E235AQ46374782-B6BBE8B4-3DF4-4E57-86F5-7187E135AE22Q46729856-AB8DC311-4653-47D4-AE87-6F0C4407C492Q47212735-AB4FDC36-D8EC-4F6B-A7C8-03DCD2F39464Q48212408-19CE4A8F-3ACA-479C-9846-F89374491B13Q49432567-9C57C550-8059-4030-BB13-20510A464944Q50291228-1AD92F2B-40EA-4BCC-B571-6ADF4D084A96
P2860
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.
@en
type
label
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.
@en
prefLabel
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.
@en
P2860
P356
P1476
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.
@en
P2093
Kiran Musunuru
Rajat M Gupta
P2860
P304
P356
10.1172/JCI72992
P407
P577
2014-10-01T00:00:00Z